Literature DB >> 25888234

Near full length hepatitis C virus genome reconstruction by next generation sequencing based on genotype-independent amplification.

Barbara Bartolini1, Emanuela Giombini1, Isabella Abbate1, Marina Selleri1, Gabriella Rozera1, Tommaso Biagini2, Ubaldo Visco-Comandini1, Chiara Taibi1, Maria Rosaria Capobianchi3.   

Abstract

BACKGROUND: Deep sequencing has a deep impact on the study of rapidly mutating RNA viruses, such as hepatitis C virus, proving to be an invaluable tool for analyzing virus diversity and evolution. AIM: Genotype-independent high-throughput pyrosequencing was used to obtain near full length hepatitis C virus genome sequence reconstruction directly from clinical samples.
METHODS: Samples from hepatitis C virus infected subjects harbouring different subtypes (1a, 1b, 2c) were analyzed (viral load range: 1.2-20.8 × 10(6)IU/ml). Data were generated with a modified sequence-independent single primer amplification method followed by 454 sequencing.
RESULTS: the extent of reconstructed hepatitis C virus genome varied from 79.95% to 99.64%. No correlation between extent of genome reconstruction and either viral load (r=0.4857, p=0.3556) or number of HCV reads (r=0.08571, p=0.9194) was observed.
CONCLUSION: This study describes a protocol for obtaining whole genome sequences from different hepatitis C virus patients with different genotypes in a single sequencing run.
Copyright © 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DAAs; Deep-sequencing; Full genome reconstruction; HCV; Modified SISPA approach

Mesh:

Substances:

Year:  2015        PMID: 25888234     DOI: 10.1016/j.dld.2015.03.015

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  1 in total

1.  A Pan-HIV Strategy for Complete Genome Sequencing.

Authors:  Michael G Berg; Julie Yamaguchi; Elodie Alessandri-Gradt; Robert W Tell; Jean-Christophe Plantier; Catherine A Brennan
Journal:  J Clin Microbiol       Date:  2015-12-23       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.